Pharmacy Times October 25, 2024
Karen M. Fancher, PharmD, BCOP, Amanda Seddon, PharmD, BCPS, BCOP

Key Takeaways

  • Hematology/oncology pharmacists enhance cancer care through medication management, complementing multidisciplinary teams in both academic and community settings.
  • Their roles include personalizing therapy, educating patients, managing adverse events, and contributing to research and advocacy efforts.
  • As cancer treatments become more complex, the demand for oncology pharmacists is rising, highlighting their importance in improving patient outcomes.
  • HOPA supports these professionals, advocating for their integral role in the cancer care continuum and promoting their involvement in various aspects of oncology care.

Their expertise complements multidisciplinary teams in a variety of clinical settings.

The Hematology/Oncology Pharmacy Association (HOPA) supports hematology/oncology pharmacy professionals and promotes the role of the pharmacist in collaborative cancer care. HOPA is celebrating 20 years of optimizing...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Pharma, Pharma / Biotech, Provider
FDA says the Zepbound shortage is over. Here’s what that means for compounding pharmacies, patients who used off-brand versions
The CMS NHE 2023 Report: An Incomplete Picture at a Pivotal Time
Mark Cuban's 2025 plans
Pharma At A Crossroads: Navigating Cost Pressures And Regulatory Shifts In 2025
Q&A: Proposed changes to Social Security Act would recognize pharmacists as healthcare providers

Share This Article